RE: Think new7 Feb 2026 07:58
Nice find wellsit,
"Although a growing body of recent research has demonstrated that improving cardiovascular health by inducing vascular rejuvenation is a promising therapeutic strategy to promote healthy aging, treating older adults with prescription medications to improve age-related vascular dysfunction in the absence of clinical disease to prevent CVD is currently unacceptable (Sun et al., 2024). Therefore, exploring new nutrition intervention strategies to induce vascular rejuvenation is critical for preventing or delaying the growing cardiovascular health problems in older people."
By-Health seems to be targeting healthy aging with this study/article.
https://zhuanlan.zhihu.com/p/2002754461647536291
"Tomson Group has long been involved in the anti-aging field. According to WISEGUY's "Global Anti-Aging Market Research Report," the global anti-aging product market reached $266.2 billion in 2024 and is projected to grow to $498.8 billion by 2032. Facing this vast market, in 2021, Tomson Group, in collaboration with the Chinese Academy of Sciences and other institutions, screened PCC1 (proanthocyanidin C1), an anti-aging substance that can effectively and safely eliminate aging cells. In June 2025, they released their latest research findings on the anti-aging natural ingredient pyrroloquinoline quinone (PQQ). If these findings are implemented, they are expected to become a core competitive advantage for the company in the anti-aging arena.
In terms of new function development, By-Health has collaborated with research institutions to conduct in-depth research and development on Fruitflow . As a water-soluble concentrate extracted from tomatoes, Fruitflow is hailed as "natural aspirin" in the industry because it helps regulate platelet aggregation and support blood flow health. Following the "Implementation Rules for the Evaluation of New Functions and Product Technologies of Health Foods (Trial)," By-Health was the first to submit an application for a new function of health food that "helps maintain normal platelet aggregation function and is beneficial to blood flow health." If this function is approved and the product is launched, it is expected to open up a new niche market of blood flow health for the company, creating considerable market growth."
and another snippet.
https://baijiahao.baidu.com/s?id=1856370486580145393&wfr=spider&for=pc
Sign In
Follow the stocks
